No Data
No Data
Alumis Inc. Approves New Severance and Control Plan
Acelyrin Stock Jumps on Concentra Acquisition Interest
Reported Earlier, ACELYRIN Confirms Unsolicited $3/Share Offer From Concentra Biosciences Amid Pending Alumis Merger
Express News | ACELYRIN Confirms Receipt of Unsolicited Indication of Interest From Concentra Biosciences
Analysts Offer Insights on Materials Companies: Alumis Inc. (ALMS) and Martin Marietta Materials (MLM)
Alumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference